Market Cap 21.15M
Revenue (ttm) 1.23M
Net Income (ttm) -13.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,090.24%
Debt to Equity Ratio 0.00
Volume 249,000
Avg Vol 193,604
Day's Range N/A - N/A
Shares Out 1.65M
Stochastic %K 50%
Beta 2.16
Analysts Strong Sell
Price Target $28.50

Company Profile

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphom...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 2 9472 4101
Address:
Three International Towers, Level 24 300 Barangaroo Avenue, Sydney, Australia
PT3
PT3 Aug. 13 at 3:43 PM
0 · Reply
PT3
PT3 Aug. 12 at 9:49 PM
$KZIA seriously good read outs coming, milestone payments coming, accumulation at higher higher SP, etc…
0 · Reply
mankind1
mankind1 Aug. 12 at 9:06 PM
$KZIA weird
1 · Reply
birdman1001
birdman1001 Aug. 12 at 7:59 PM
$KZIA Shorts painting the tape.
0 · Reply
Rinnekin
Rinnekin Aug. 12 at 2:12 PM
$KZIA The start of recruitment for this study will trigger a milestone payment by Sovargen to Kazia.
2 · Reply
LabMan
LabMan Aug. 12 at 3:52 AM
$KZIA In March 2024, Kazia Therapeutics signed an exclusive global licensing agreement with Sovargen to develop and commercialize paxalisib for rare central nervous system conditions involving intractable seizures, specifically focal cortical dysplasia type 2 (FCD T2) and tuberous sclerosis complex (TSC). A modest upfront payment to Kazia will now be made, pending commencement of the start of the trial this week. Significant in that once again paxalisib provides a compelling story, as the only brain penetrate Pi3k mTOR drug that crosses the blood brain barrier.
0 · Reply
PT3
PT3 Aug. 11 at 6:05 PM
$KZIA trend is nice and will keep doing low volume drops and accumulation upward until one day it explodes. I have been buying dips.
1 · Reply
jacckkmm
jacckkmm Aug. 11 at 1:39 PM
$STIM I like that a major investor .. Jorey Chernett Major Shareholder Is involved with this stock .. he appears to be a winner! I recognize his name from $KZIA Where it appears he is invested also.. a stock I love too.. Good financial companies and private investors is something I like seeing!
1 · Reply
LabMan
LabMan Aug. 11 at 6:01 AM
$KZIA "New Approach to Cancer Treatment " would mean a drug of immeasurable worth. It is a strong possibility, we have it here with the ability of paxalisib to epigenetically modify cancer & allow immunorthpy to work in the body. There is a big pharma rush to develop such a drug, in solid tumors. AstraZenica said to have dozens of scientists working on such a drug. Again we see a broker out, completely oblivious to Kazia Theriputics - and likely success in this field. Epigigenetics & cancer treatment - A hundred billion dollar drug, is supported by recent publications available to all investors to research. Selling comes from up to 80 percent of even the current register, who simply do not understand. Prof Rao & Kazia are well advanced, with this folio below, serving to highlight the impact of such a drug ( in actual fact, the paper is targeting an enzyme that deruglates the PI3K mTOR pathway). A future here of immense excitement - of which many investors don't understand.
0 · Reply
jacckkmm
jacckkmm Aug. 10 at 5:33 PM
$SLS and $KZIA Two of my favorites One up $.52 one down $.54 .. go figure .. push!
0 · Reply
Latest News on KZIA
Kazia Therapeutics initiated with a Buy at BTIG

2026-07-01T10:41:06.000Z - 6 weeks ago

Kazia Therapeutics initiated with a Buy at BTIG


Kazia Therapeutics initiated with a Buy at Lake Street

2026-06-11T11:46:17.000Z - 2 months ago

Kazia Therapeutics initiated with a Buy at Lake Street


Kazia Therapeutics appoints James Levine as CFO

2026-06-02T12:29:05.000Z - 2 months ago

Kazia Therapeutics appoints James Levine as CFO


Kazia Therapeutics initiated with a Buy at Laidlaw

2026-04-15T09:06:21.000Z - 4 months ago

Kazia Therapeutics initiated with a Buy at Laidlaw


Kazia Therapeutics trading resumes

2026-01-02T21:00:10.000Z - 7 months ago

Kazia Therapeutics trading resumes


Kazia Therapeutics trading halted, volatility trading pause

2026-01-02T20:50:08.000Z - 7 months ago

Kazia Therapeutics trading halted, volatility trading pause


Kazia Therapeutics regains Nasdaq compliance

2025-12-22T13:12:06.000Z - 8 months ago

Kazia Therapeutics regains Nasdaq compliance


Kazia Therapeutics Regains Full Nasdaq Listing Compliance

Dec 22, 2025, 8:00 AM EST - 8 months ago

Kazia Therapeutics Regains Full Nasdaq Listing Compliance


Kazia Therapeutics trading resumes

2025-12-02T14:45:14.000Z - 9 months ago

Kazia Therapeutics trading resumes


Kazia Therapeutics trading halted, volatility trading pause

2025-12-02T14:40:42.000Z - 9 months ago

Kazia Therapeutics trading halted, volatility trading pause


Kazia Therapeutics announces pricing of $50M private placement

2025-12-02T14:15:20.000Z - 9 months ago

Kazia Therapeutics announces pricing of $50M private placement


KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER

Sep 12, 2024, 7:30 AM EDT - 2 years ago

KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER


Kazia announces presentation of new data at AACR Annual Meeting

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Kazia announces presentation of new data at AACR Annual Meeting


KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS

Jan 18, 2024, 7:30 AM EST - 2 years ago

KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS


KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION

Nov 20, 2023, 4:30 PM EST - 2 years ago

KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION


Kazia announces voluntary delisting from ASX

Oct 11, 2023, 7:01 AM EDT - 3 years ago

Kazia announces voluntary delisting from ASX


PT3
PT3 Aug. 13 at 3:43 PM
0 · Reply
PT3
PT3 Aug. 12 at 9:49 PM
$KZIA seriously good read outs coming, milestone payments coming, accumulation at higher higher SP, etc…
0 · Reply
mankind1
mankind1 Aug. 12 at 9:06 PM
$KZIA weird
1 · Reply
birdman1001
birdman1001 Aug. 12 at 7:59 PM
$KZIA Shorts painting the tape.
0 · Reply
Rinnekin
Rinnekin Aug. 12 at 2:12 PM
$KZIA The start of recruitment for this study will trigger a milestone payment by Sovargen to Kazia.
2 · Reply
LabMan
LabMan Aug. 12 at 3:52 AM
$KZIA In March 2024, Kazia Therapeutics signed an exclusive global licensing agreement with Sovargen to develop and commercialize paxalisib for rare central nervous system conditions involving intractable seizures, specifically focal cortical dysplasia type 2 (FCD T2) and tuberous sclerosis complex (TSC). A modest upfront payment to Kazia will now be made, pending commencement of the start of the trial this week. Significant in that once again paxalisib provides a compelling story, as the only brain penetrate Pi3k mTOR drug that crosses the blood brain barrier.
0 · Reply
PT3
PT3 Aug. 11 at 6:05 PM
$KZIA trend is nice and will keep doing low volume drops and accumulation upward until one day it explodes. I have been buying dips.
1 · Reply
jacckkmm
jacckkmm Aug. 11 at 1:39 PM
$STIM I like that a major investor .. Jorey Chernett Major Shareholder Is involved with this stock .. he appears to be a winner! I recognize his name from $KZIA Where it appears he is invested also.. a stock I love too.. Good financial companies and private investors is something I like seeing!
1 · Reply
LabMan
LabMan Aug. 11 at 6:01 AM
$KZIA "New Approach to Cancer Treatment " would mean a drug of immeasurable worth. It is a strong possibility, we have it here with the ability of paxalisib to epigenetically modify cancer & allow immunorthpy to work in the body. There is a big pharma rush to develop such a drug, in solid tumors. AstraZenica said to have dozens of scientists working on such a drug. Again we see a broker out, completely oblivious to Kazia Theriputics - and likely success in this field. Epigigenetics & cancer treatment - A hundred billion dollar drug, is supported by recent publications available to all investors to research. Selling comes from up to 80 percent of even the current register, who simply do not understand. Prof Rao & Kazia are well advanced, with this folio below, serving to highlight the impact of such a drug ( in actual fact, the paper is targeting an enzyme that deruglates the PI3K mTOR pathway). A future here of immense excitement - of which many investors don't understand.
0 · Reply
jacckkmm
jacckkmm Aug. 10 at 5:33 PM
$SLS and $KZIA Two of my favorites One up $.52 one down $.54 .. go figure .. push!
0 · Reply
_peewee_
_peewee_ Aug. 10 at 5:18 PM
$KZIA $14.40 (3.71%)
0 · Reply
_peewee_
_peewee_ Aug. 10 at 3:12 PM
0 · Reply
jacckkmm
jacckkmm Aug. 10 at 2:54 PM
$KZIA to the moon Alice…
0 · Reply
mankind1
mankind1 Aug. 10 at 2:07 PM
$KZIA finally
0 · Reply
futureexmillionare
futureexmillionare Aug. 10 at 1:49 PM
$KZIA We tired 3 times to break through ... Lets see if this time will be a charm.
0 · Reply
LabMan
LabMan Aug. 9 at 2:45 AM
$KZIA Deep into their clinical trial, - this surely unprecented company news release, relevant to the fight against cancer and development of new oncology drugs. From a management, known to be conservative and restrained. It takes a read and re read to fully absorb the impact of its meaning " supported....by patient data". There is strong potential for a major gap, followed by chaotic stock trading, when further data lands from this study. A 200% SP increase even in the short term, far understates paxalisib epergentic breakdown of solid tumor cancer and associated circulation tumor cells or CTC. QUOTE Kazia Therapeutics Ltd 28 July 2026 Clinically relevant perioperative studies demonstrate elimination of residual disease and prevention of metastatic spread, supported by complementary translational patient data
2 · Reply
BullStockpicks1
BullStockpicks1 Aug. 8 at 7:01 AM
$KZIA https://x.com/bullstkpicks/status/2085801268505608293?s=46&t=cyjtCnUcMDe5-ZCjxf5y_w
0 · Reply
StantheMan32
StantheMan32 Aug. 8 at 12:16 AM
0 · Reply
harambe_reborn
harambe_reborn Aug. 7 at 7:52 PM
$KZIA print some 14s into the close
0 · Reply
harambe_reborn
harambe_reborn Aug. 7 at 7:38 PM
$KZIA more chunky buys again today she wants to gasm so hard i can taste it
0 · Reply
mankind1
mankind1 Aug. 7 at 7:11 PM
$KZIA are people finally starting to see this guy?
0 · Reply
_peewee_
_peewee_ Aug. 7 at 6:38 PM
$GP $PSEC $ZIM $KZIA runners :-)
1 · Reply